TIME- Text-based intervention to minimize the time burden of routine cancer care

TIME- Text-based intervention to minimize the time burden of routine cancer care
Enrolling By Invitation
18 years - 99 years
All
Phase N/A
300 participants needed
1 Location

Brief description of study

The research study is being conducted to evaluate and test a text message-based strategy to streamline care. Our text message-based triage would screen patients before they come to the clinic, allowing patients with no side effects and normal bloodwork to get their infusion without having to wait. To ensure this is safe, we will first test the performance of the message-based system to accurately identify those patients experiencing side-effects. Next, we will use a randomized control study to measure how much time the triage system reduces and gives back to the patients.

This project will help us better understand how to use technology to improve the patient experience. Participants that join the study will be asked to complete the following research procedure. A survey will be given prior to the office visit asking about side effects related to the participants cancer treatment. This will be compared to those responses to the note that your provider writes. We will compare the responses to the survey and the office visit to make sure that our triage system is effective.

Participation will last only for the duration of the survey.

There is no direct benefit to participants from this study. No financial compensation is provided for this study.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: cancer,immunotherapy
  • Age: 18 years - 99 years
  • Gender: All


Updated on 04 Aug 2024. Study ID: 849166
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research